Skeletal phenotyping of patients with Osteogenesis Imperfecta
- Conditions
- Brittle Bone DiseaseOsteogenesis Imperfecta10028396
- Registration Number
- NL-OMON51155
- Lead Sponsor
- Isala Klinieken
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 120
- Patients with Osteogenesis Imperfecta
- Adult (>18 years)
- Recent DEXA-scan ( < 3 years)
- Patients whose mobility does not allow proper and comfortable positioning for
scan acquisition due to extreme bowing of the extremities. Pre-screening on the
basis of already performed radiographs.
- Patients who have had a fracture at recent medical history (<2 years) at both
distal radii and tibiae.
- Patients who have had a malignancy at recent medical history (<2 years), who
have been treated with glucocorticoids less than 3 months ago, who have severe
kidney disease (eGFR <30 ml/min) or who suffer from other metabolic diseases
affecting bone.
- Female patients who are pregnant.
Study & Design
- Study Type
- Observational invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <p>The main outcome parameter is bone strength at the standard scan region,<br /><br>obtained with HR-pQCT-based micro-finite element (µFE-) analysis, in terms of<br /><br>bone stiffness and failure load. Additionally, volumetric bone and tissue<br /><br>mineral density and cortical and trabecular microarchitecture will be assessed<br /><br>with HR-pQCT. More specifically, density parameters include total, cortical,<br /><br>and trabecular volumetric bone and tissue mineral density. Microarchitecture<br /><br>parameters include trabecular bone volume fraction, number, thickness, and<br /><br>separation, and cortical thickness and porosity.</p><br>
- Secondary Outcome Measures
Name Time Method <p>-</p><br>